INDBInternet News Database 2.5 Updated 1 min ago · 293 sources Show or hide images Light or dark

Anti-Lp(a) Drug Lowers Target but Not CV Events

1 source1 article First seen Updated United States Truth score 38

Save Like Comments Compare coverage

Summary

A trial of an antisense oligonucleotide shows a robust reduction in lipoprotein(a) doesn’t carry over to cardiovascular events, but researchers won’t give up on the target.

Description from Medscape.

Who is covering this

  1. Medscape Center Factuality: Mostly factual US
    Anti-Lp(a) Drug Lowers Target but Not CV Events

    A trial of an antisense oligonucleotide shows a robust reduction in lipoprotein(a) doesn’t carry over to cardiovascular events, but researchers won’t give up on the target.

Comments

Comments need JavaScript.